CY1106132T1 - Παραγωγα πιπepιδινης ως αναστολεις καναλιου καλιου - Google Patents

Παραγωγα πιπepιδινης ως αναστολεις καναλιου καλιου

Info

Publication number
CY1106132T1
CY1106132T1 CY20061101043T CY061101043T CY1106132T1 CY 1106132 T1 CY1106132 T1 CY 1106132T1 CY 20061101043 T CY20061101043 T CY 20061101043T CY 061101043 T CY061101043 T CY 061101043T CY 1106132 T1 CY1106132 T1 CY 1106132T1
Authority
CY
Cyprus
Prior art keywords
pipeidine
derivatives
potassium channel
channel inhibitors
inhibitors
Prior art date
Application number
CY20061101043T
Other languages
English (en)
Inventor
Tomas Eriksson
Ghazi Noori
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of CY1106132T1 publication Critical patent/CY1106132T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

Η εφεύρεση παρέχει ενώσεις του τύπου
CY20061101043T 2001-12-14 2006-07-27 Παραγωγα πιπepιδινης ως αναστολεις καναλιου καλιου CY1106132T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0104251A SE0104251D0 (sv) 2001-12-14 2001-12-14 Novel compounds
PCT/SE2002/002304 WO2003051839A1 (en) 2001-12-14 2002-12-11 Novel compounds

Publications (1)

Publication Number Publication Date
CY1106132T1 true CY1106132T1 (el) 2011-06-08

Family

ID=20286353

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20061101043T CY1106132T1 (el) 2001-12-14 2006-07-27 Παραγωγα πιπepιδινης ως αναστολεις καναλιου καλιου

Country Status (14)

Country Link
EP (1) EP1499590B8 (el)
AT (1) ATE325095T1 (el)
AU (1) AU2002359122A1 (el)
CA (1) CA2487365C (el)
CY (1) CY1106132T1 (el)
DE (1) DE60211223T2 (el)
DK (1) DK1499590T3 (el)
ES (1) ES2261773T3 (el)
HK (1) HK1071134A1 (el)
MY (1) MY128924A (el)
PT (1) PT1499590E (el)
SE (1) SE0104251D0 (el)
TW (1) TWI255185B (el)
WO (1) WO2003051839A1 (el)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR028948A1 (es) 2000-06-20 2003-05-28 Astrazeneca Ab Compuestos novedosos
US7723509B2 (en) 2003-04-17 2010-05-25 Alnylam Pharmaceuticals IRNA agents with biocleavable tethers
EP2664672A1 (en) 2003-04-17 2013-11-20 Alnylam Pharmaceuticals Inc. Modified iRNA agents
US8796436B2 (en) 2003-04-17 2014-08-05 Alnylam Pharmaceuticals, Inc. Modified iRNA agents
US7851615B2 (en) 2003-04-17 2010-12-14 Alnylam Pharmaceuticals, Inc. Lipophilic conjugated iRNA agents
US8017762B2 (en) 2003-04-17 2011-09-13 Alnylam Pharmaceuticals, Inc. Modified iRNA agents
CA2617127A1 (en) * 2005-08-01 2007-02-08 Astrazeneca Ab Novel piperidine derivatives as chemokine receptor modulators useful for the treatment of respiratory diseases.
TW200738635A (en) * 2005-08-02 2007-10-16 Astrazeneca Ab New salt
TW200734305A (en) * 2005-08-02 2007-09-16 Astrazeneca Ab New salt III
TW200738634A (en) * 2005-08-02 2007-10-16 Astrazeneca Ab New salt
RU2008108176A (ru) * 2005-08-26 2009-10-10 Астразенека Аб (Se) Комбинация соединений, которая может быть применена в лечении респеративных заболеваний, особенно хронического обструктивного заболевания легких (copd) и астмы
TW200744612A (en) * 2005-08-26 2007-12-16 Astrazeneca Ab New combination
DE602006013258D1 (de) 2005-12-21 2010-05-12 Hoffmann La Roche Stabile, hERG darstellende Zellkulturen
US20080064884A1 (en) * 2006-05-10 2008-03-13 Astrazeneca Ab Novel Process 1
GB0702456D0 (en) 2007-02-08 2007-03-21 Astrazeneca Ab New combination
US20110136843A1 (en) * 2007-02-23 2011-06-09 Tomas Eriksson Novel Combination of Compounds to be Used in the Treatment of Airway Diseases, Especially Chronic Obstructive Pulmonary Disease (COPD) and Asthma
WO2008121065A1 (en) * 2007-03-30 2008-10-09 Astrazeneca Ab Novel pyrrolidine derivatives as antagonists of the chemokine receptor
JP2011507593A (ja) 2007-12-20 2011-03-10 アストラゼネカ・アクチエボラーグ 粉末８５４を脱凝集解体する装置ならびに方法
MX2011003800A (es) 2008-10-08 2011-06-16 Astrazeneca Ab Inhalador con indexacion ligada al movimiento de la tapa.
TW201036957A (en) 2009-02-20 2010-10-16 Astrazeneca Ab Novel salt 628
CN102711883B (zh) 2009-07-01 2015-04-08 阿斯利康(瑞典)有限公司 用于在气流中夹带粉末的分配器和方法
GB0913345D0 (en) 2009-07-31 2009-09-16 Astrazeneca Ab New combination 802
WO2011061527A1 (en) 2009-11-17 2011-05-26 Astrazeneca Ab Combinations comprising a glucocorticoid receptor modulator for the treatment of respiratory diseases
WO2011073662A1 (en) 2009-12-17 2011-06-23 Astrazeneca Ab Combination of a benzoxazinone and a further agent for treating respiratory diseases
EP2534054A1 (en) 2010-02-10 2012-12-19 AstraZeneca UK Limited Process for providing a filled canister for an inhaler
CN103118727B (zh) 2010-07-21 2015-11-25 阿斯利康(瑞典)有限公司 吸入器
RU2013104024A (ru) 2010-07-21 2014-08-27 Астразенека Аб Ингалятор
GB201021979D0 (en) 2010-12-23 2011-02-02 Astrazeneca Ab New compound
GB201021992D0 (en) 2010-12-23 2011-02-02 Astrazeneca Ab Compound
WO2012163848A1 (en) 2011-05-27 2012-12-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of crohn's disease
GB201115874D0 (en) 2011-09-14 2011-10-26 Astrazeneca Ab Inhaler
GB201115870D0 (en) 2011-09-14 2011-10-26 Astrazeneca Ab Inhaler

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO5300399A1 (es) * 2000-02-25 2003-07-31 Astrazeneca Ab Heterocicliocs que contienen nitrogeno, proceso para su preparacion y composiciones farmaceuticas que los contienen

Also Published As

Publication number Publication date
EP1499590B8 (en) 2006-08-02
CA2487365A1 (en) 2003-06-26
SE0104251D0 (sv) 2001-12-14
EP1499590B1 (en) 2006-05-03
PT1499590E (pt) 2006-08-31
EP1499590A1 (en) 2005-01-26
WO2003051839A1 (en) 2003-06-26
TW200409631A (en) 2004-06-16
ES2261773T3 (es) 2006-11-16
ATE325095T1 (de) 2006-06-15
TWI255185B (en) 2006-05-21
DE60211223T2 (de) 2007-04-19
MY128924A (en) 2007-02-28
CA2487365C (en) 2009-06-16
DE60211223D1 (de) 2006-06-08
AU2002359122A1 (en) 2003-06-30
HK1071134A1 (en) 2005-07-08
DK1499590T3 (da) 2006-07-31

Similar Documents

Publication Publication Date Title
CY1106132T1 (el) Παραγωγα πιπepιδινης ως αναστολεις καναλιου καλιου
SE0000540D0 (sv) New compounds
CY1106247T1 (el) Θειοφαινο- και θειαζολοσουλφοναμιδες ως αντινεοπλαστικοι παραγοντες
DK1483265T3 (da) Purinderivater som kinaseinhibitorer
UY28290A1 (es) Compuestos farmacéuticos novedosos
NO20041493L (no) Kjemiske forbindelser.
UY28625A1 (es) Nuevos compuestos farmacéuticos
ATE400567T1 (de) Kinaseinhibitoren
DE60335359D1 (de) Phthalazinonderivate
CY1105386T1 (el) Βενζοϋλοσουλφοναμιδια και σουλφονυλβενζαμιδινες για χρηση σαν παραγοντες κατα του ογκου
ATE389638T1 (de) Aminobenzamidderivate als inhibitoren der glycogensynthasekinase-3-
SE0202465D0 (sv) New compounds
EA200501928A1 (ru) Пирролодигидроизохинолины как ингибиторы pde10
DE60135919D1 (de) Farnesyl transferase-hemmende 6-heterocyclylmethyl-chinolin und chinazol-derivate
DE60219521D1 (de) Aryloxyphenyl und arylsulfanylphenylderivate
IL163777A0 (en) Kinase inhibitors
EA200801145A1 (ru) Спироциклические производные хиназолина в качестве ингибиторов pde7
SV2006002001A (es) Inhibidores de quinasa ref. x - 16437
EA200801365A1 (ru) Замещенные 5-фенил-3,6-дигидро-2-оксо-6h-1,3,4-тиадиазины
BR0313969A (pt) Inibidores de oxitocina
SE0103710D0 (sv) Compounds
EA200801366A1 (ru) Производные 3,6-дигидро-2-оксо-6н-1,3,4-тиадиазина
ATE417849T1 (de) Pyrazoloä4,3-düpyrimidine
ZA200404752B (en) 6-aminomorphinane derivatives method for the production and use thereof
DE60316984D1 (de) Benzoylsulfonamide als antitumor-mittel